Literature DB >> 18191610

Type II transmembrane serine proteases in development and disease.

Roman Szabo1, Thomas H Bugge.   

Abstract

Recent advances in the mammalian genome projects have resulted in the identification of a surprisingly large number of genes encoding putative new members and even entire new families of proteolytic enzymes. In the past few years, one of these new families, type II transmembrane serine proteases (TTSPs), underwent a particularly rapid transformation from a group of predicted DNA and protein sequences into an established family of cell surface-associated proteases with important roles in the development and homeostasis of mammalian tissues such as heart, skin, inner ear, placenta, and digestive tract. Additionally, aberrant expression of TTSP genes appears to be involved in the aetiology of several human disorders, including cancer. This review presents our current knowledge of the biological functions of the individual TTSPs in mouse and human tissue development and disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18191610     DOI: 10.1016/j.biocel.2007.11.013

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  70 in total

1.  Membrane-type MMPs are indispensable for placental labyrinth formation and development.

Authors:  Ludmila Szabova; Mee-Young Son; Joanne Shi; Marek Sramko; Susan S Yamada; William D Swaim; Patricia Zerfas; Stacie Kahan; Kenn Holmbeck
Journal:  Blood       Date:  2010-09-21       Impact factor: 22.113

Review 2.  The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment.

Authors:  Toni M Antalis; Marguerite S Buzza; Kathryn M Hodge; John D Hooper; Sarah Netzel-Arnett
Journal:  Biochem J       Date:  2010-06-15       Impact factor: 3.857

Review 3.  Type II transmembrane serine proteases.

Authors:  Thomas H Bugge; Toni M Antalis; Qingyu Wu
Journal:  J Biol Chem       Date:  2009-06-01       Impact factor: 5.157

Review 4.  Proteases: multifunctional enzymes in life and disease.

Authors:  Carlos López-Otín; Judith S Bond
Journal:  J Biol Chem       Date:  2008-07-23       Impact factor: 5.157

5.  Laminin-332 cleavage by matriptase alters motility parameters of prostate cancer cells.

Authors:  Manisha Tripathi; Alka A Potdar; Hironobu Yamashita; Brandy Weidow; Peter T Cummings; Daniel Kirchhofer; Vito Quaranta
Journal:  Prostate       Date:  2011-02-01       Impact factor: 4.104

6.  Energetic and structural basis for activation of the epithelial sodium channel by matriptase.

Authors:  Pradeep Kota; Agustin García-Caballero; Hong Dang; Martina Gentzsch; M Jackson Stutts; Nikolay V Dokholyan
Journal:  Biochemistry       Date:  2012-04-09       Impact factor: 3.162

7.  The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis.

Authors:  Jared M Lucas; Cynthia Heinlein; Tom Kim; Susana A Hernandez; Muzdah S Malik; Lawrence D True; Colm Morrissey; Eva Corey; Bruce Montgomery; Elahe Mostaghel; Nigel Clegg; Ilsa Coleman; Christopher M Brown; Eric L Schneider; Charles Craik; Julian A Simon; Antonio Bedalov; Peter S Nelson
Journal:  Cancer Discov       Date:  2014-08-13       Impact factor: 39.397

8.  TMPRSS4 correlates with colorectal cancer pathological stage and regulates cell proliferation and self-renewal ability.

Authors:  Ao Huang; Houmin Zhou; Hongchao Zhao; Yingjun Quan; Bo Feng; Minhua Zheng
Journal:  Cancer Biol Ther       Date:  2013-12-12       Impact factor: 4.742

9.  The cell-surface anchored serine protease TMPRSS13 promotes breast cancer progression and resistance to chemotherapy.

Authors:  Andrew S Murray; Thomas E Hyland; Kimberley E Sala-Hamrick; Jacob R Mackinder; Carly E Martin; Lauren M Tanabe; Fausto A Varela; Karin List
Journal:  Oncogene       Date:  2020-08-31       Impact factor: 9.867

10.  Loss of matriptase suppression underlies spint1 mutation-associated ichthyosis and postnatal lethality.

Authors:  Roman Szabo; Peter Kosa; Karin List; Thomas H Bugge
Journal:  Am J Pathol       Date:  2009-04-23       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.